Tenaya Therapeutics (TNYA) Treasury Shares (2020 - 2026)

Tenaya Therapeutics' Treasury Shares history runs 7 years deep, the most recent figure standing at $2.5 million for Q1 2026.

• In Q1 2026, Treasury Shares rose 10.85% year-over-year to $2.5 million; the TTM figure through Mar 2026 stood at $2.5 million (up 10.85% YoY), while the FY2025 annual figure was $1.5 million, up 13.44% from the prior year.
• Treasury Shares was $2.5 million for Q1 2026 at Tenaya Therapeutics, up from $1.5 million in the prior quarter.
• In the past five years, Treasury Shares ranged from a high of $2.5 million in Q1 2026 to a low of $61537.0 in Q3 2022.
• Historically, Treasury Shares has averaged $1.3 million across 5 years, with a median of $1.4 million in 2024.
• The sharpest annual moves came in 2022 and 2026: Treasury Shares soared 20696.99% in 2022, then grew 10.85% in 2026.
• A 5-year view of Treasury Shares shows it stood at $459192.0 in 2022, then soared by 137.0% to $1.1 million in 2023, then gained by 24.43% to $1.4 million in 2024, then rose by 13.44% to $1.5 million in 2025, then soared by 63.9% to $2.5 million in 2026.
• The last three Treasury Shares figures came in at $2.5 million (Q1 2026), $1.5 million (Q4 2025), and $1.7 million (Q3 2025), per Business Quant data.